ZA884040B - Canine coronavirus vaccine - Google Patents

Canine coronavirus vaccine

Info

Publication number
ZA884040B
ZA884040B ZA884040A ZA884040A ZA884040B ZA 884040 B ZA884040 B ZA 884040B ZA 884040 A ZA884040 A ZA 884040A ZA 884040 A ZA884040 A ZA 884040A ZA 884040 B ZA884040 B ZA 884040B
Authority
ZA
South Africa
Prior art keywords
ccv
canine coronavirus
vaccine
coronavirus vaccine
cell
Prior art date
Application number
ZA884040A
Other languages
English (en)
Inventor
Michael Alonzo Gill
Alonzo Gill Michael
Stephen Wayne May
Wayne May Stephen
Original Assignee
Norden Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norden Lab Inc filed Critical Norden Lab Inc
Publication of ZA884040B publication Critical patent/ZA884040B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA884040A 1987-06-08 1988-06-07 Canine coronavirus vaccine ZA884040B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/059,437 US4904468A (en) 1987-06-08 1987-06-08 Canine coronavirus vaccine

Publications (1)

Publication Number Publication Date
ZA884040B true ZA884040B (en) 1989-09-27

Family

ID=22022943

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884040A ZA884040B (en) 1987-06-08 1988-06-07 Canine coronavirus vaccine

Country Status (20)

Country Link
US (1) US4904468A (de)
EP (1) EP0295057B1 (de)
JP (1) JP2655876B2 (de)
KR (1) KR970000233B1 (de)
AT (1) ATE91902T1 (de)
AU (1) AU612151B2 (de)
CA (1) CA1337267C (de)
DE (1) DE3882599T2 (de)
DK (1) DK175410B1 (de)
ES (1) ES2058283T3 (de)
FI (1) FI87531C (de)
HU (1) HU203984B (de)
IE (1) IE63006B1 (de)
IL (1) IL86635A0 (de)
MY (1) MY103575A (de)
NO (1) NO176004C (de)
NZ (1) NZ224865A (de)
PH (1) PH27018A (de)
PT (1) PT87668B (de)
ZA (1) ZA884040B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5911999A (en) * 1987-09-28 1999-06-15 Pfizer, Inc. Vaccine based on TGEV for protection of dogs against canine coronavirus
ZA903142B (en) * 1989-05-03 1991-02-27 Akzo Nv Canine corona virus vaccine
US5672350A (en) * 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
KR100186783B1 (ko) * 1990-04-24 1999-05-01 게리 왁톤; 산티노 디-지아코모 적혈구와 표면-결합된 항원을 포함하는 경구용 백신
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
ATE256746T1 (de) * 1991-04-25 2004-01-15 Akzo Nobel Nv Subeinheits-impfstoff gegen hundecoronavirus
EP0524672A1 (de) * 1991-06-27 1993-01-27 Duphar International Research B.V CCV-Impfstoff
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
DE69332375T2 (de) * 1992-05-08 2003-02-13 Pfizer Hundecoronavirus s gen und verwendung davon
US5750112A (en) * 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
DE602005025649D1 (de) * 2005-10-26 2011-02-10 Canio Buonavoglia Pantropisches Hundecoronavirus
US7761389B2 (en) 2007-08-23 2010-07-20 Gm Global Technology Operations, Inc. Method for anomaly prediction of battery parasitic load
AU2010306752B2 (en) * 2009-10-14 2015-05-28 The Board Of Regents For Oklahoma State University Isolation of a virus related to canine parvovirus-2 from a raccoon
SG11201503854UA (en) 2012-11-22 2015-06-29 Asahi Kasei Medical Co Ltd Method for producing parvovirus having high infectivity titer
CN106290880B (zh) * 2015-05-27 2019-01-04 江苏雷森生物科技有限公司 一种用于犬冠状病毒的免疫层析用试剂组合物及检测方法
EP3372677B8 (de) 2015-11-06 2019-09-25 Asahi Kasei Medical Co., Ltd. Verfahren zur herstellung eines parvovirus mit hohem infektiositätstiter und hoher reinheit
CN110903387A (zh) * 2019-12-17 2020-03-24 吉林省纽卓莱生物科技有限责任公司 一种犬冠状病毒免疫球蛋白F(ab′)2及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567042A (en) * 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5032520A (en) * 1985-03-29 1991-07-16 National Research Development Corporation DNA sequences encoding infectious bronchitis virus spike protein

Also Published As

Publication number Publication date
IL86635A0 (en) 1988-11-30
US4904468A (en) 1990-02-27
FI882689A (fi) 1988-12-09
FI882689A0 (fi) 1988-06-07
DK301588A (da) 1988-12-09
HU203984B (en) 1991-11-28
ATE91902T1 (de) 1993-08-15
EP0295057A2 (de) 1988-12-14
ES2058283T3 (es) 1994-11-01
DE3882599D1 (de) 1993-09-02
JPS63316739A (ja) 1988-12-26
NZ224865A (en) 1990-12-21
JP2655876B2 (ja) 1997-09-24
EP0295057B1 (de) 1993-07-28
MY103575A (en) 1993-08-28
DK175410B1 (da) 2004-09-27
IE63006B1 (en) 1995-03-22
CA1337267C (en) 1995-10-10
PT87668B (pt) 1992-09-30
KR890000105A (ko) 1989-03-11
PT87668A (pt) 1988-07-01
DK301588D0 (da) 1988-06-02
PH27018A (en) 1993-02-01
KR970000233B1 (ko) 1997-01-08
NO882500D0 (no) 1988-06-07
EP0295057A3 (en) 1989-12-27
NO176004B (no) 1994-10-10
FI87531C (fi) 1993-01-25
NO882500L (no) 1988-12-09
DE3882599T2 (de) 1994-02-10
FI87531B (fi) 1992-10-15
AU1747688A (en) 1988-12-08
HUT46858A (en) 1988-12-28
IE881689L (en) 1988-12-08
AU612151B2 (en) 1991-07-04
NO176004C (no) 1995-01-18

Similar Documents

Publication Publication Date Title
IL86635A0 (en) Canine coronavirus vaccine
ES2042751T3 (es) Nuevo procedimiento para la purificacion de viriones de la hepatitis a.
DK0639640T3 (da) Fjerkrævaccine indeholdende smitsomt bronchitis-virus serotype 4/91
DK0465204T3 (da) Vaccine mod Lyme sygdom
NZ314585A (en) Method of treating H. Pylori associated gastroduodenal disease
IE802141L (en) Vaccine
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
DE3853672D1 (de) Nichtzurückschlagende RNS-Viren.
IL100386A0 (en) Cell free marek's disease virus vaccine
AU653861B2 (en) Respiratory disease vaccine for cats
EP0485463A4 (en) Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ES2084587T3 (es) Arn virus no revertientes.